Table:
begin	end	state
1	6	cytoplasmic
7	35	transmembrane
36	46	non-cytoplasmic
47	73	transmembrane
74	81	cytoplasmic
82	128	transmembrane
129	136	cytoplasmic
137	160	transmembrane
161	171	non-cytoplasmic
172	194	transmembrane
195	216	cytoplasmic
217	235	transmembrane
236	240	non-cytoplasmic
241	242	transmembrane
243	245	non-cytoplasmic
246	263	transmembrane
264	315	cytoplasmic
316	336	transmembrane
337	347	non-cytoplasmic
348	370	transmembrane
371	377	cytoplasmic
378	396	transmembrane
397	401	non-cytoplasmic
402	429	transmembrane
430	434	cytoplasmic
435	462	transmembrane
463	476	non-cytoplasmic

Input:
>WP_043917824.1 NCBI__GCF_000877395.1:WP_043917824.1
MEVVLLFTMIIGLLLVGVPIAVSLGFSSIIFLLAFSDTSLASIAQSFYQAMAGHYTLLAI
PFFILASSFMSTGGVARRIIRFSIACVGHLRGGLAIAGVFACMMFAALSGSSPATVVAIG
TIVIAAMKQAGYTKDFAAGVICNAGTLGILIPPSIVMVVYASATDVSVGRMFLAGVVPGL
MAGLMLMITIYVIARIKDMPKGEFAGWGEVGASFRDAFWGLMLIVIIMIGIYGIPGVTGA
IFTPTEAAAVASVYAFIVAMFIYRDIGPLAPRPAQSVGAAVAGPVEGTPKSLFSAPWALL
TAFVHRDTRDTLFEAGKLTIMLMFIIANALILKHVLTDEQIPQHIAEAMLSAGLGPITFL
IVVNVILLIGGQFMEPSGLLVIVAPLVFPIAIELGIDPIHLGIIMVVNMEIGMITPPVGL
NLFVTSGVAGMSMMAVVRAALPFLAVLFVFLILVTYIPAISLTLPHAIMGPETIIR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server